3,4-dihydroxyphenylacetic acid and isoxazoles

3,4-dihydroxyphenylacetic acid has been researched along with isoxazoles in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's3 (33.33)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biggio, G; Casu, M; Corda, MG; Gessa, GL; Vernaleone, F1
Fukushima, Y; Hirano, T; Ishida, M; Kaneko, S; Kondo, T; Okada, M; Otani, K1
Beart, PM; Lloyd, KG; Scatton, B1
Furukawa, H; Hasegawa, T; Kitaichi, K; Nabeshima, T; Yamada, K1
Fukushima, Y; Hirano, T; Kaneko, S; Kondo, T; Mizuno, K; Okada, M; Otani, K1
Gluck, MR; Granson, H; Santana, LA; Yahr, MD1
Choudhury, ME; Kubo, M; Nagai, M; Nishikawa, N; Nomoto, M; Yabe, H1
Buckley, B; Sonsalla, PK; Winnik, B; Wong, LY1
Asano, T; Hikawa, R; Takahashi, R; Uemura, MT; Yamakado, H1

Other Studies

9 other study(ies) available for 3,4-dihydroxyphenylacetic acid and isoxazoles

ArticleYear
Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain.
    Life sciences, 1977, Aug-15, Volume: 21, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Aminobutyrates; Animals; Brain; Caudate Nucleus; Diazepam; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; gamma-Aminobutyric Acid; Homovanillic Acid; Isoxazoles; Male; Mice; Motor Activity; Oxazoles; Phenobarbital

1977
Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release.
    Epilepsy research, 1992, Volume: 13, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Biogenic Monoamines; Calcium; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Hippocampus; Homovanillic Acid; Isoxazoles; Male; Rats; Rats, Wistar; Zonisamide

1992
Subchronic administration of GABAergic agonists elevates [3H]GABA binding and produces tolerance in striatal dopamine catabolism.
    Brain research, 1985, May-27, Volume: 335, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Alkynes; Aminocaproates; Aminooxyacetic Acid; Animals; Baclofen; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Isoxazoles; Male; Pyrones; Rats; Rats, Inbred Strains; Vigabatrin

1985
Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
    Japanese journal of pharmacology, 1994, Volume: 66, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Frontal Lobe; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Isoxazoles; Locomotion; Male; Phencyclidine; Piperidines; Random Allocation; Rats; Rats, Wistar; Risperidone; Ritanserin; Schizophrenia; Serotonin; Stereotyped Behavior

1994
Effects of zonisamide on dopaminergic system.
    Epilepsy research, 1995, Volume: 22, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Enzyme Inhibitors; Extracellular Space; Hippocampus; Hydrazines; Isoxazoles; Male; Microdialysis; Monoamine Oxidase; Neostriatum; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase; Zonisamide

1995
Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity.
    Journal of neural transmission (Vienna, Austria : 1996), 2004, Volume: 111, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Homovanillic Acid; Isoxazoles; Levodopa; Microdialysis; Oxidopamine; Parkinson Disease; Rats; Zonisamide

2004
Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
    Journal of pharmacological sciences, 2009, Volume: 110, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Biogenic Amines; Brain Chemistry; Callithrix; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Homovanillic Acid; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neostriatum; Neurons; Selegiline; Zonisamide

2009
The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance.
    Experimental neurology, 2010, Volume: 221, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antioxidants; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glutathione; Isoxazoles; Male; Mass Spectrometry; Mice; Monoamine Oxidase; MPTP Poisoning; Regression, Psychology; Tyrosine 3-Monooxygenase; Zonisamide

2010
Zonisamide inhibits monoamine oxidase and enhances motor performance and social activity.
    Neuroscience research, 2017, Volume: 124

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Astrocytes; Brain; Dopamine; Exploratory Behavior; Homovanillic Acid; Isoxazoles; Locomotion; Male; Mice, Inbred C57BL; Monoamine Oxidase; Neurons; Parkinson Disease; Social Behavior; Zonisamide

2017